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Abstract
Background: The effects of acute and repeated treatment with desipramine on the functional
response of α2-adrenoceptors were tested in adult and 13-day old rats. The functional response
measured was hypothermia that was induced by brimonidine, an α2-adrenoceptor agonist. The
change in the extent of the brimonidine-induced hypothermia following pretreatment with either
single or 4 twice-daily injections of desipramine was compared in 13-day old and adult (65–75 days
old) male rats.
Results: Brimonidine, alone, lowered rectal temperature to a greater extent in juvenile than in
adult rats, and this response was dose-dependently blocked by the selective α2-adrenoceptor
antagonist, RX821002, in both groups of rats. Single desipramine administration lowered rectal
temperature in the absence of brimonidine in adult but not in juvenile rats. The adult rats developed
tolerance to this hypothermic effect after 4 days of desipramine treatment (10 mg/kg twice daily).
Repeated desipramine treatment of adult rats also resulted in an enhancement in the brimonidine-
induced hypothermic effect 24 h after the last dose, a time when above 90% of desipramine and its
metabolite, desmethyldesipramine, had cleared the brain, but not at 14, 48 or 96 h after the last
dose. In juvenile rats repeated injections of desipramine (3 mg/kg twice daily for 4 days) had no
effect on the α2-agonist-induced hypothermia when brimonidine was given 14, 24, 63 and 96 h after
the last dose of desipramine.
Conclusion: The results suggest that juvenile rats response differently than adult rats to agonist
stimulation of α2-adrenoceptors with and without pretreatment with the antidepressant
desipramine. In the absence of desipramine pretreatment, the α2-adrenoceptor-induced
hypothermic effect in juvenile rats is greater than in adult rats. Acute injections of desipramine, in
the absence of agonist produced a hypothermic effect in adult but not juvenile rats. In addition, the
increased α2-agonist-induced hypothermic effect following repeated injections of desipramine that
is seen in adult rats is not seen in juvenile rats.
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Background
Although an immediate effect of tricyclic antidepressants
is to inhibit the norepinephrine transporter, the antide-
pressant effects of the drug are most likely related to fur-
ther downstream effects that occur following repeated
administration. It was suggested many years ago that the
effects of antidepressants are related to the down-regula-
tion of either adrenergic and/or serotonergic receptors
which occur over time suggesting that multiple steps are
involved. The tricyclic antidepressant, desipramine, is
known to down-regulate the β-adrenoceptor in adult rat
cortices following treatment for a little as four days [1-3].
The α1- and α2-adrenoceptor densities are not affected by
four days of twice daily desipramine injections in adult
rats [4]. It is well known that children don't respond to the
antidepressant effects of the tricyclic antidepressants [5,6].
Several studies now indicate that juvenile rats also
respond differently to tricyclic antidepressants as com-
pared to adult rats. Studies in post-natal day 13 rats dem-
onstrate that repeated desipramine treatment down-
regulates the cortical β-adrenoceptors in a manner similar
to that seen in adult rats [4]; however, the α1-adrenocep-
tor in the cortex and the α2-adrenoceptor in the prefrontal
cortex are up-regulated rather than down-regulated fol-
lowing 4 days of twice a day desipramine treatment [4].
Furthermore, in post-natal day 21 rats selective serotonin
reuptake inhibitors, but not tricyclic antidepressants, are
positive in the forced-swim test, an animal model of anti-
depressant action, and in the learned helplessness model
of depression [7]. These results suggest that the α2-adren-
ergic systems in juvenile rats may not function in the same
manner as seen in adult rats.
The purpose of this study was to determine whether the
changes in α2-adrenoceptor densities seen following
repeated desipramine injections in juvenile rats [4] result
in a change in a functional response of α2-adrenoceptors.
If so does this functional response also occur in adult rat
brains, or is there a significant difference between the α2-
adrenoceptor-mediated functional response in juvenile
and adult rat brains following repeated desipramine injec-
tions. A functional α2-adrenoceptor response that can be
easily measured in post-natal day 13 as well as adult rats
is the decrease in rectal temperature. Following α2-agonist
administration the body temperature falls several degrees
over a 90 min time period and then returns to normal.
Confirmation that this is an α2-adrenoceptor response is
the fact that dexmedetomidine, an α2-agonist, does not
cause a hypothermic response in mice lacking the α2A-
adrenoceptor [8]. In this study the effects of acute and
repeated desipramine treatment on the α2-agonist-
induced hypothermic response was compared in post-
natal day 9–12 and adult (65–75 day old) rats.
Methods
Drugs
Brimonidine was purchased from Sigma Aldrich (St.
Louis, MO) and dissolved in DMSO and then diluted 10-
fold in saline. RX821002 (Methoxyidazoxan; Tocris, Ellis-
ville, MO) and desipramine (Sigma Aldrich, St. Louis,
MO) were dissolved in water and sterilized by filtration.
Animals
Male Sprague Dawley rats from Harlan Industries (Indian-
apolis, IN) were maintained on rat lab chow in conven-
tional rat cages for 6 to 7 days prior to start of the
experiment with a 12 h light dark cycle. The adult rats
were between 250 g and 280 g (approximately 59–63 days
old) when they arrived and were housed three to a cage,
they were allowed to acclimate to the facilities for 1 week
prior to use. Juvenile male rats were shipped on post-natal
day 1 and arrived on post-natal day 2. The liter was culled
to 9 rats on day 3. Whenever possible, 9 pups were left
with the dam throughout the experiment, however, pups
that were significantly underweight or that did not appear
to be developing appropriately were removed. Procedures
used were in strict accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Ani-
mals and were approved by the UNMC Animal Care Com-
mittee.
Hypothermic response
The adult rats (65 to 75 days old) were housed two to a
wire cage during the hypothermic experiments and were
prevented from lying one on top of each other. The PD13
rats were placed in an open plastic rat shipping container
with divisions. Young rats maintain their body tempera-
ture by lying on top of each other or lying next to the dam.
When separated from their liter mates they tend to shiver.
During the hypothermic experiments the rats were not
allowed to lay on top of each other because that could
produce uneven changes in body temperature during the
experiments. In order to help maintain a warm environ-
ment for the post-natal day 13 rats, a heating pad that con-
trolled the environmental temperature between 28 and
30°C, was placed under the container in order to main-
tain a temperature comparable to what the pups experi-
enced with the dam. The pups were allowed to move to an
area that was not in contact with the heating pad so that
they did not over heat as required by the animal facility.
Most of the rats stayed on the heating pad although a few
rats would wander around the container at times. As
shown below, the heating pad did not interfere with the
ability of an α2-adrenoceptor agonist to produce changes
in rectal temperature in the juvenile rats. A heating pad
was not used for the adult rats because they do not have
difficulty maintaining their body temperature. The rats
were grouped according to the dose of drug administered.
Rats in each group were allowed to be close to each otherBMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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but not on top of each other and not close to rats in other
groups. If a rat moved on top of another rat, it was gently
raised by the nap of the neck and rotated to the side of the
other rat. For all of these experiments, rats were moved to
a separate procedure room shortly before starting the
experiment. All measurements of body temperature were
started between 7:30 am and 8:00 am.
Rectal temperature was determined on rats that had been
gently restrained by wrapping in a towel using a 0.025
inch diameter flexible probe for the juvenile rats and a
0.125 inch diameter animal rectal probe for adult rats
with a Thermalert Monitoring Thermometer (Physitemp-
Clifton, NJ). The equilibration time for the probes was
less than a second, and the probes were held in place until
the meter reading equilibrated which took less than 10
sec. An initial temperature was taken on all rats to allow
them to acclimate to having their temperature taken and
to the room. This initial temperature reading was not used
in the data analysis. Thirty minutes later the temperature
was again determined (0 time).
Brimonidine and RX821002 administration paradigm
Except in the acute desipramine study, the decrease in rec-
tal temperature was initiated by immediately injecting
(i.p.) either brimonidine in 10% DMSO or 10% DMSO
(controls). The adult rat's rectal temperature was meas-
ured 30, 60, 90 and 120 min later. The hypothermic effect
lasted longer in the juvenile rats than the adult rats and
therefore the temperatures for the juvenile rats were meas-
ured 30, 60, 90, and either 120 or 135 min later. Multiple
doses of drugs were used in any one experiment along
with two or more control rats. The number of rats used at
each dose of brimonidine is given in Table 1.
In some experiments, RX821002 (dissolved in water) was
administered to the rats and the rectal temperature was
measured at 30 min followed immediately by brimoni-
dine administration. The rats' temperatures were then
measured at the times given above. Dilutions of the drugs
were prepared so the adult rats were receiving 1.0 ml/kg
and the juvenile rats received 0.1 ml/20 g. The number of
rats per dose for the different treatment paradigms is given
in Table 1. In all experiments the change in temperature
was calculated based on the temperature at 0 time.
Desipramine administration paradigm
In the acute studies, rats' rectal temperatures were meas-
ured at 0 time, and 1 min later they were given a single
injection of either water (controls) or desipramine (10
mg/kg for adult rats and 3 mg/kg for juvenile rats). The
rats' temperature was measured 30 min and 60 min later.
Immediately after the 60 min temperature recordings the
rats were given brimonidine (1 mg/kg for adult rats and
0.6 mg/kg for juvenile rats) and the rectal temperature of
the rat was measured at 30, 60, 90 and 120 min later for
the adult rats and 45, 90, 135 min later for the post-natal
day 13 rats. There were 4 animals in each group; however
one of the post-natal day 13 rats receiving desipramine
was eliminated from the analysis because of lack of a bri-
monidine effect (see statistical analysis section).
In the repeated desipramine treatment paradigm, rats
were given an i.p. injection of either desipramine or water
(controls) at about 7:30 am and 5:30 p.m. each day for 4
days (8 injections/rat). The adult rats received 10 mg/kg
(10 mg/ml) of desipramine and the juvenile rats received
3 mg/kg (0.6 mg/ml) starting either the evening of post-
natal day 8 or the morning of post-natal day 9. The hypo-
thermic experiments were started at 7:30 am either 14, 24,
48, 63 or 96 hours after the last dose of desipramine. The
number of rats in each group is given in the figure legends.
The rats were euthanized 3 (adult rats) or 4 h (juvenile
rats) after the brimonidine injection at the end of the
hypothermic experiment. The brain was quickly removed
and the cerebellum removed and frozen (-20°C) for later
measurement of brain desipramine and the active metab-
olite desmethyldesipramine concentrations. The
desipramine and desmethyldesipramine concentrations
were measured as previously reported [9].
Statistical methods
To determine whether the desipramine-treated animals
had a different hypothermic response compared to the
control animals, the change in rectal temperature over
time starting at the 0 time point was calculated and the
data were analyzed using a 2-way ANOVA with repeated
measures using the SPSS statistical program (SPSS Inc.,
Chicago, IL) for changes in dose, time and time × dose. If
the sphericity in the Mauchly's test was less than 0.05, the
Greenhouse-Geisser test was used to determine if there
was a significant difference over time, otherwise sphericity
was assumed. We noticed that some animals had an
abnormal response to brimonidine. Any animal who had
less than 0.5 degree temperature change 90 min after the
brimonidine injection was eliminated from the statisti-
cally analysis (7/81 adult rats and 1/75 juvenile rats). A
few of the pups had an abnormally low weight gain over
the four days. Because the brain does not develop well in
underweight pups, the experimental results for any pup
weighing 16 g or less on the day of the hypothermic exper-
iment was eliminated (5/80 rats). When appropriate, a
Students t-test was used to determine significant differ-
ences between drug and control conditions. To determine
where there was an acute effect of desipramine in adult
and juvenile rats 30 and 60 min after i.p. injection, the
data were analyzed using a 2-way ANOVA (PRISM, Graph-
pad, San Diego, CA) followed by a Bonferroni posttest
when the ANOVA results were significant.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Table 1: Administration paradigms for brimonidine and RX821002 dose-response curves. 
Age of rat at beginning of dosing Drug 1 Dose (mg/kg) Drug 2 Dose (mg/kg) # of Rats
Brimonidine Dose Response
65 to 75 Brimonidine in 10% DMSO 0 None 8
0.1 6
0.3 4
0.6 8
1.0 6
1.5 7
24
13 Brimonidine in 10% DMSO 0 None 4
0.1 4
0.3 4
0.6 4
0.8 4
1.0 3
Antagonism of Brimonidine by RX821002
65 to 75 RX821002 in water 0 Brimonidine in 10% DMSO 0 8
01 1 0
0.02 1 4
0.05 1 4
0.1 1 4
0.1 0 2
13 RX821002 in water 0 Brimonidine in 10% DMSO 0.6 4
0.02 0.6 4
0.04 0.6 4
0.08 0.6 4
0.08 0 4
Drug solutions were prepared so that the adult rats received 0.1 ml/100 gm and the post-natal day 13 rats received 0.1 ml/20 gm. The control rats 
received the same solvent as used for preparing the drug.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Results
Dose-response relationship of brimonidine-induced 
decrease in rectal temperature
Initial experiments were conducted to determine the opti-
mal dose of brimonidine for subsequent experiments. We
defined the optimal dose as the dose that produced about
75% of the maximal observed hypothermic effect. The
temperature of the rats was measured (0 time) just before
injecting brimonidine in order to establish a baseline.
Juvenile rats received doses of brimonidine between 0 and
1.0 mg/kg and adult rats between 0 to 2.0 mg/kg, and
their rectal temperatures were taken at various times there-
after.
In adult rats, brimonidine produced a dose-dependent
decrease in rectal temperature (Fig. 1). At low doses (0.1
and 0.3 mg/kg), the maximum decrease in rectal temper-
ature occurred at 60 min with a maximum drop in rectal
temperature of 2°C. By 90 min the temperature had
returned to baseline. As the dose of brimonidine
increased, the duration of the hypothermic effect also
increased, and at the higher doses (1 to 2 mg/kg) the max-
imum effect occurred at 90 min. We also noted a behavio-
ral change in the rats that received higher doses of
brimonidine. At 0.3 mg/kg the rats appeared to be lightly
sedated but remained standing. At 0.6 and 1.0 mg/kg the
rats were sedated and were often lying down 30 min after
the brimonidine injections. At 2 mg/kg the adults had
shallow respiration and appeared to be asleep, yet when
picked up to measure their temperature they would move
around. When placed back in the cage they would become
still again. The animals injected with the lower doses of
brimonidine also recovered faster from the sedative effects
of the drug. We did not test doses higher than 2 mg/kg
because of the anesthetic-like effects of the drug. The exact
EC50 for brimonidine cannot be calculated because of the
lack of a full dose response curve. For subsequent experi-
ments in adult rats we used a dose of brimonidine of 1
mg/kg which produces 75% of the response seen at a bri-
monidine dose 2 mg/kg.
The post-natal day13 rats were more sensitive to the
effects of brimonidine than the adult rats as evidenced by
an increased extent and longer duration of decreased rec-
tal temperature (Fig. 1). This could be due in part to dif-
ferences in rate of metabolism and/or clearance of
brimonidine between the two age groups. The juvenile
rats which received only 10% DMSO (control rats) main-
tained a relatively constant temperature (mean change =
0.4 ± 0.2°C) throughout the experiment. The maximal
effect of 0.1 mg/kg brimonidine occurred at 90 min com-
pared to 60 min in the adult rats. At higher doses (0.3 to
1 mg/kg) the temperature was still dropping at 135 min.
The temperature was not measured at longer periods of
time because repeated insertions of the probe were irritat-
ing to the rats. At 90 min the maximum drop in rectal tem-
perature was 7°C at a dose of 1 mg/kg. A dose of 0.6 mg/
kg brimonidine produced 74% of the 1 mg/kg effect and
this dose of brimonidine was used in subsequent experi-
ments. Behavioral effects of brimonidine in the juvenile
rats could be seen at doses as low as 0.1 mg/kg. Juvenile
rats receiving 0.1 mg/kg to 0.8 mg/kg initially tried to
climb out of the cage but then fell asleep within 8 min of
the brimonidine injection. At the lower doses of brimoni-
dine, taking the rats temperature was enough to arouse
them, and when placed back into their cage they would try
to climb out again. After a few minutes they would fall
back to sleep. Rats that received 1 mg/kg were sedated
within 5 min of the brimonidine injection. The control
(10% DMSO in saline) animals appeared to sleep nor-
mally and did not try to climb out of their cage. As with
the adults, the young rats receiving the highest injection of
the drug took the longest to recover. They would wake up
when handled to take their temperature but then fall back
to sleep when placed back in their cage.
The hypothermic effect of brimonidine is mediated by the 
α2-adrenoceptor
The rats were given either water or RX821002, a selective
α2-adrenoceptor antagonist, 30 min prior to the brimoni-
dine injection, in order to confirm that the hypothermic
effect of brimonidine is due to an action on the α2-adren-
oceptor and not imidazoline or serotonin receptors. In
this experimental paradigm rats were injected with water
or RX821002 at -30 min. The rectal temperature was
measured at 0 time followed by an injection of brimoni-
dine (1 mg/kg for adult rats and 0.6 mg/kg for post-natal
day13 rats). Temperatures were determined at various
times thereafter. The brimonidine-induced changes from
the 0 time temperature at various concentrations of
RX821002 are presented in Fig. 2. In both juvenile and
adult rats the extent of the hypothermic effect decreased as
the dose of RX821002 increased. In adult rats, 100 μg/kg
of RX821002 produced a drop in rectal temperature of 1.3
± 0.3°C 90 min after giving brimonidine, compared to a
3.7 ± 0.2°C drop in the absence of RX821002. In the juve-
nile animals, a dose of 80 μg/kg of RX821002 blocked
most of the hypothermic effect produced by brimonidine.
In both adult and juvenile animals, RX821002 also
blocked the sedative effects of brimonidine. RX821002
alone had minimal effect on the adult and post-natal day
13 rats (Fig. 2).
Effects of acute desipramine on rectal temperature
Because the direct action of desipramine is to block the
norepinephrine transport which results in increases syn-
aptic norepinephrine, acute administration of
desipramine by itself could have hypothermic effects.
Adult and post-natal day 13 rats were given a single injec-
tion of either water (control) or desipramine (10 and 3BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Figure 1 (see legend on next page)BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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mg/kg, respectively) immediately after determining their
rectal temperatures. The rectal temperature was measured
again 30 and 60 min after the desipramine injection. Pre-
vious studies have demonstrated that 3 mg/kg in post-
natal day 13 rats results in similar brain desipramine con-
centrations to those obtained in adult rats when they are
given a single acute injection of 10 mg/kg of desipramine
[9]. In the adult rats there was a small, but significant drop
(P  < 0.002) in rectal temperature at 30 and 60 min
(1.5°C) after the desipramine injection (Fig. 3) based on
a repeated measures 2-way ANOVA followed by a Bonfer-
roni posttest of drug effect. In juvenile animals there was
no significant difference in body temperature at these two
time points (Fig 3).
The presence of desipramine could also affect brimoni-
dine-induced decreases in rectal temperature. Both the
control and desipramine-treated rats were given brimoni-
dine immediately after taking the 60 min rectal tempera-
ture and the body temperatures determined at various
times thereafter. A repeat measure 2-way ANOVA of the
temperature change from the time of giving desipramine
until the last temperature measurement indicated no sig-
nificant difference (P  > 0.05) between drug and water
treated juvenile or adult rats.
Effect of repeated desipramine on rectal temperature
The rectal temperature immediately prior to giving brimo-
nidine to the animals treated with desipramine for four
days was compared to those of rats who received injection
of water for four days (Table 2). In the adult rats the rectal
temperature was 1.4°C lower (P < 0.05) 48 h after the last
desipramine injection than in the control animals, how-
ever no significant differences were seen 14, 24 and 96 h
after the last dose. In the juvenile animals the only signif-
icant difference (P < 0.05) was found 14 h after the last
desipramine dose with the controls being slightly warmer
(0.6°C).
Effects of repeated desipramine pretreatment on 
brimonidine-induced decrease in rectal temperature
In order to determine whether repeated desipramine treat-
ment altered the functional response of α2-adrenoceptors
in juvenile and adult rats in a similar manner, both ages
of rats were given desipramine or water twice daily for
four days and brimonidine-induced decrease in rectal
temperature was determined. The adult rats received 10
mg/kg/injection of desipramine, which is a dose previ-
ously shown by us and others to down-regulate the β-
adrenoceptors [4,10] and to be effective in the learned
helplessness model of depression [7]. In the post-natal
day 9–12 animals, the dose of drug used (3 mg/kg/injec-
tion) has been previously shown in our laboratory to give
similar brain desipramine concentration as in the adult
animals receiving 10 mg/kg/injection [9]. This dose
down-regulates the β-adrenoceptor, and up-regulates the
α1- and α2-adrenoceptors [4]. Desmethyldesipramine, an
active metabolite desipramine, is equally potent with
desipramine in down-regulating the β-adrenoceptor in
rats [10]. Three hours after a single acute injection of
desipramine (10 mg/kg in adults and 3 mg/kg in juve-
niles) the concentration of desipramine was similar in
both age groups (Table 3). In rats treated with
desipramine for four days, 17 to 18 h after the last dose,
the desipramine concentrations in the adult and juvenile
rats were comparable; however the desmethyld-
esipramine concentration in the adult rats was five-fold
higher than the juvenile rats. The clearance of the
desipramine from the brain was faster in the adult ani-
mals than in the juvenile rats (Table 3) with greater than
99% elimination of the drug occurring in 52 h for the
adult rats and 100 h for the juvenile rats.
The brimonidine-induced decreases in rectal temperature
were initiated at various times after the last dose of water
or desipramine because it was not known if the hypother-
mic effect would occur when desipramine was present in
the brain and how long the hypothermic effect resulting
from repeated desipramine treatment would last after
desipramine and desmethyldesipramine were eliminated
from the brain. In adult rats, a significantly (P = 0.002)
Brimonidine-induced decrease in rectal temperature in adult and post-natal day 13 rats Figure 1 (see previous page)
Brimonidine-induced decrease in rectal temperature in adult and post-natal day 13 rats. Upper panel: The 
change in rectal temperature of adult rats immediately before (0 time) brimonidine administration and 30, 60, 90 and (in some 
experiments) 120 min after brimonidine injection (i.p.) of 0, 0.1, 0.3, 0.6, 1, 1.5 or 2 mg/kg. The average rectal temperature for 
adult rats at time 0 was 35.1 ± 0.2°C and the number of rats at each dose is given in Table 1. Middle Panel:The change in rectal 
temperature of post-natal day 13 rats immediately before (0 time) brimonidine administration and 30, 60, 90, 120 and 135 min 
after brimonidine injection (i.p.) of 0, 0.1, 0.3, 0.6, 0.8 or 10 mg/kg with 3 to 6 rats per dose. The average rectal temperature at 
time 0 for post-natal day13 rats was 34.4 ± 0.2°C and the number of rats at each dose is given in Table 1. Lower Panel: 
Changes in rectal temperature in both adult and post-natal day 13 rats as a function of dose at 90 min. Data were analyzed 
using nonlinear regression analysis of an exponential decay equation. The two curves are statistically different using an F-test (P 
< 0.006). Error bars indicate S.E.M.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Figure 2 (see legend on next page)BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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greater hypothermic effect was obtained in treated com-
pared to control rats 24 h after the last dose of
desipramine (Fig. 4), a time when 90% of the drug and its
metabolite had been eliminated from the brain (Table 3).
No significant differences in the rectal temperatures were
observed between control and desipramine treated rats 14
h after the last dose when the brain desipramine + des-
methyldesipramine concentrations were very high or 52 h
after the last dose when the desipramine + desmethyld-
esipramine concentrations were negligible (Fig. 4, Table
3). In contrast, in the juvenile rats there were no signifi-
cant differences in rectal temperatures between rats that
had received desipramine versus those only receiving
vehicle at 14, 24, 63 or 96 h after the last dose (Fig. 5).
Discussion
The most noteworthy findings of these studies are the sig-
nificant differences in the α2-adrenoceptor induced-hypo-
thermic response in juvenile rats as compared to adult rats
after acute and repeated pretreatment with desipramine.
The lack of a hypothermic response of the juvenile ani-
mals to acute desipramine treatment and the lack of effect
of repeated desipramine administration on the brimoni-
dine-induced hypothermia suggest differences in the func-
tion of the norepinephrine transporter and/or the
regulation of α2-adrenoceptor in juvenile compared to
adult rats.
α2-Agonist-induced decreases in rectal temperature
In rats, a hypothermic effect can be produced by stimulat-
ing the α2-adrenoceptor, presynaptic 5HT1A [11], and pos-
sibly imidazoline receptors. Most of the hypothermic
studies in rats have been conducted using compounds
that are not highly selective for the α2-adrenoceptor, such
as clonidine. Although clonidine is an α2-agonist, it also
binds with high affinity to imidazoline sites, although this
was not appreciated at the time most of the studies were
conducted. The hypothermic effects of clonidine can be
blocked by idazoxan [12] a compound that has a higher
affinity for the imidazoline sites than the α2-adrenocep-
tor. However, the clonidine effect is also blocked by
yohimbine [13], a compound with high affinity for the
α2-adrenoceptor and low affinity for the imidazoline sites,
but this compound also binds to the 5-HT1A, 5HT1B, 5-
HT1D and dopamine D2 sites [14]. Mice lacking the α2A-
adrenoceptor do not respond to the hypothermic effects
of dexmedetomidine, which has both α2-adrenoceptor
and imidazoline effects [8].
Because the purpose of this study was to look at the func-
tional response of α2-agonists following repeated
desipramine treatment, it was important to demonstrate
the hypothermic effect was mediated by α2-adrenoceptors
in the rat, rather than through imidazoline or serotonin
mechanisms. We chose to use the brimonidine, which has
good selectivity for the α2-adrenoceptor, although it also
has some interaction with imidazoline sites. The brimoni-
dine-induced decrease in rectal temperature was blocked
by RX821002, a highly selective α2-antagonist that did not
alter rectal temperature on its own, confirming an α2-
adrenergic-mediated mechanism. In addition the hypo-
thermic effect of brimonidine has been shown to be
blocked by repeated infusion of antisense oligonucle-
otides to the α2A-adrenoceptor in the rat [15].
The hypothermic effects of brimonidine have not been
studied previously in juvenile rats. These studies indicate
that it is possible to measure a α2-agonists induced hypo-
thermia in post-natal day 13 rats since the temperature of
the control rats remained relatively constant throughout
repeated temperature measurements and the brimonidine
induced effects were significant with 4 to 7°C temperature
changes at the higher doses of brimonidine. We found,
that, as in adults, the hypothermic effect in juvenile rats
was dose-dependent and reversed by RX821002. Major
differences between the two age groups were a) a greater
temperature change in the post-natal day 13 rats at lower
doses of brimonidine compared to adult rats; b) the
effects of brimonidine lasted longer in the post-natal day
13 rats compared to adult rats; and c) the juvenile rats
Blockade of brimonidine effects by RX821002 Figure 2 (see previous page)
Blockade of brimonidine effects by RX821002. Either RX821002 or water was administered by i.p. injection 30 min prior 
to brimonidine. At time 0 the rectal temperature was taken, and the rat was immediately injected with brimonidine or saline. 
Rectal temperatures were then taken at various times thereafter, and the change in temperature from time 0 was calculated. 
Adult rats (upper panel; 2 to 10 rats per group). Average baseline temperature was 35 ± 0.2°C. An ANOVA of the change in 
temperature at the 90 min point indicates a significant difference (P < 0.001) between the 0 and the 50 and 100 μg/kg dose of 
RX821002 in the presence of brimonidine. However there was no statistical difference between animals receiving neither bri-
monidine and RX821002 and those receiving RX821002 alone (p > 0.05). Post-natal day 13 rats (lower panel). Number of rats 
at each dose is given in Table 1, and the average temperature of rats at 0 time was 35.0 ± 0.2°C for adult rats and 33.1 ± 0.2°C 
for post-natal day 13 rats. Error bars are S.E.M. An ANOVA of the change in temperature at the 90 min point indicates a signif-
icant difference (P < 0.01) between the 0 and the 80 μg/kg dose of RX821002 in the presence of brimonidine. However there 
was no statistical difference between animals receiving both brimonidine and 80 μg/kg RX821002 and those receiving 
RX821002 alone (P > 0.05).BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Effect of acute desipramine on rectal temperature Figure 3
Effect of acute desipramine on rectal temperature. A single i.p. injection of either water or desipramine (DMI) was 
given to adult (10 mg/kg) and post-natal day 13 (3 mg/kg) rats immediately after measuring their rectal temperatures (0 time). 
The rectal temperatures were measured again at 30 min and 60 min. Immediately thereafter brimonidine was injected (1 and 
0.6 mg/kg i.p. for adult and post-natal day 13 rats, respectively) and rectal temperature determined at the times noted. The 
mean change in rectal temperature ± S.E.M. from the zero time for each rat is given. Number of rats in the control and 
desipramine treated groups was 4 for adult rats and 4 and 3 for juvenile rats, respectively. *Significantly different (P < 0.001) 
than control rats at that time point and age group based on 2-way ANOVA followed by a Bonferroni post-test of the body 
temperatures prior to administration of brimonidine.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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exhibited behavioral effects not seen in the adult rats. It
has been previously reported that clonidine produced
behavioral effects in post-natal day 10 rats consisting pri-
marily of locomotion in open areas and wall climbing
[16]. These effects were blocked by phentolamine and
phenoxybenzamine.
Hypothermic effects of desipramine in juvenile compared 
to adult rats
Because desipramine increases synaptic norepinephrine
concentrations, it would be expected to indirectly produce
a hypothermic effect. Indeed, in adult rats an acute injec-
tion of desipramine produced a hypothermic effect in the
absence of brimonidine. This effect of desipramine was
not additive with that of brimonidine. This lack of an
additive effect could be partially due to elimination of
desipramine from the brain as desipramine has a half-life
of elimination from the adult rat brain following a single
injection of 10 mg/kg of 3.3 h [9]. Others have reported
no hypothermic effect due to an acute injection of 10 mg/
kg of desipramine [17-19]. In our studies, the adult rats
appeared to develop tolerance to the desipramine effects
with repeated injections, because rats that had twice daily
injections of desipramine for four days had a similar rectal
temperature to those that only received an injection of
water.
Neither acute nor repeated desipramine injections pro-
duced a consistent hypothermic effect in juvenile rats,
even though desipramine concentration in the juvenile
brains was similar to those in the adult brains. This could
be due to the fact that the norepinephrine transporter is
Table 2: Comparison of desipramine-treated and control rat rectal temperatures at various times after the last dose of desipramine in 
the 4-day treatment paradigm. 
Adult Rats Postnatal Day 13 – 16 Rats
Time after last dose Control Desipramine Time after last dose Control Desipramine
14 h 34.4 ± 0.2 (4) 34.6 ± 0.4 (4) 14 h 34.2 ± 0.2 (3) 33.6 ± 0.2a (5)
24 h 34.4 ± 0.2 (12) 34.5 ± 0.1 (12) 24 h 33.9 ± 0.1 (14) 33.6 ± 0.2 (12)
48 h 35.3 ± 0.2 (14) 33.9 ± 0.1a (13) 63 h 35.3 ± 0.1 (11) 35.3 ± 0.3 (14)
96 h 34.7 ± 0.2 (8) 34.3 ± 0.1 (7) 96 h 35.0 ± 0.1 (13) 34.9 ± 0.2 (9)
Juvenile rats received the last injection on post-natal day 12. A student t-test was used to compare the temperatures of the control versus the 
desipramine treated rats prior to giving brimonidine. Values are temperature in°C ± S.E.M. Number of rats in each group is given in parenthesis.
aSignificantly different than control at P < 0.05
Table 3: Concentration of desipramine and desmethyldesipramine (DDMI) in the cerebellum of rats at the end of the hypothermic 
experiments.
Adult Rats Post-natal Day 9–12 Rats
Time 
(h)
Desipramine 
(ng/g)
DDMI 
(ng/g)
Desipramine + DDMI 
(ng/g)
Time 
(h)
Desipramine 
(ng/g)
DDMI 
(ng/g)
Desipramine + DDMI 
(ng/g)
Acute Treatment Acute Treatment
3 1880 ± 130 430 ± 95 2310 3 1500 ± 140 100 ± 17 1600
Repeated Treatment Repeated Treatment
17 4010 ± 640 2710 ± 150 6720 18 3750 ± 190 530 ± 31 4280
27 220 ± 50 510 ± 79 730 28 2550 ± 480 440 ± 16 2540
52 12 ± 12 34 ± 34 46 67 82 ± 50 55 ± 18 137
100 ND ND ND 100 18 ± 10 2 ± 2 20
Rats that had been treated either acutely or for four days with desipramine (same animals as those in Fig. 4–5) were decapitated under isoflurane 
anesthesia at the completion of the hypothermic experiment (3 to 4 h after giving brimonidine) and the desipramine concentration ± S.E.M. in the 
cerebellum was determined. The time given in the table is the time after the last dose of desipramine. Thus the 27 hour data in this table, for 
example, come from the same animals as the 24 hour data in Fig. 4. The number of rats in each group is given in the legends for Fig. 1–3.
ND: Not determined, but assumed to be essentially 0.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Brimonidine induced changes in rectal temperature after 4-days of desipramine treatment in adult rats Figure 4
Brimonidine induced changes in rectal temperature after 4-days of desipramine treatment in adult rats. Rats 
were injected twice a day for four days with 10 mg/kg desipramine (DMI) or vehicle starting in either the morning or the 
evening. Measurements of rectal temperature were conducted the same time each morning 14, 24, 48 and 96 h after the last 
desipramine/water dose. The rectal temperature was taken immediately prior (0 time) to giving brimonidine (1.0 mg/kg) and 
then 30, 60, 90 and 120 min thereafter. Data points are the average change in rectal temperature from the zero time tempera-
ture for each group of rats. The number of rats used in the 14, 24, 48 and 96 h experiments were 4, 12,14 and 8 control and 4, 
12, 13 and 7 desipramine treated rats, respectively. Change in temperature with drug concentration is statistically different (P < 
0.05) 24 hr after the last dose. The change in rectal temperature with time is statistically significant (P < 0.001) for all experi-
ments.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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Brimonidine induced changes in rectal temperature after 4-day desipramine treatment in juvenile rats Figure 5
Brimonidine induced changes in rectal temperature after 4-day desipramine treatment in juvenile rats. Rats 
were injected twice a day for four days with water or 3 mg/kg desipramine (DMI) starting either the evening of post-natal day 
8 or the morning of post-natal day 9. The measurements in rectal temperature were conducted the same time each morning 
14, 24, 63, and 96 h after the last desipramine/water dose. The rectal temperature was taken immediately prior (0 time) to giv-
ing brimonidine (0.6 mg/kg) and then 45, 90 and 135 min thereafter. Data points are the average change in rectal temperature 
from the zero time temperature for each group of rats. The number of rats used in the 14, 24, 64 and 96 h studies was 3, 14, 
11 and 13 control rats and 5, 12, 14 and 9 desipramine treated rats, respectively. The change in rectal temperature with time is 
statically significantly (P < 0.05) different for all experiments.BMC Pharmacology 2008, 8:17 http://www.biomedcentral.com/1471-2210/8/17
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not fully developed at post-natal day 13 [20] and thus
there may have been an insufficient increase in norepine-
phrine to cause a hypothermic effect. Regional increases
in synaptogenesis, adrenoceptor densities and norepine-
phrine transporter density in rats have been reported
between post-natal day 10 and 20 [20]. The highest den-
sity of receptors occurs around post-natal day 20 to 30 in
many regions of the brain and then declines to adult lev-
els. Rats reach sexual maturity around post-natal day 35
which corresponds roughly to puberty or early adoles-
cence. Another potential explanation for the lack of a
desipramine effect in the juvenile rats is that α2-adreno-
ceptors are not fully functional in this age group [21].
However, this explanation is not likely because brimoni-
dine produced a significant hypothermic effect in the
post-natal day 13 rats.
α2-Agonist-induced hypothermic response following 
repeated desipramine treatment of adult and juvenile rats
It has been previously shown that effective treatment of
animals with desipramine is dependent on both dose and
time of treatment [1-3]. The 4-day treatment paradigm
was used in these studies because we and others have
found that this paradigm causes an increase in α1- and α2-
adrenoceptors in post-natal day 13 rats [4] and a decrease
in β-adrenoceptor density in both adult [4,10] and juve-
nile animals [4]. In addition, this dose of desipramine will
prevent the development of learned helplessness in adult
rats [22-24]. The dose of the desipramine used in the juve-
nile animals was previously demonstrated to give brain
concentrations of desipramine plus its active metabolite,
desmethyldesipramine, similar to that found in adult rats
[9]. The studies reported here confirm that 3 mg/kg/injec-
tion twice a day for four days starting on post-natal day 9
produces brain concentrations of desipramine + desmeth-
yldesipramine at post-natal day 13 that are comparable to
those seen in adult rats given 10 mg/kg/injection twice a
day for four days.
It is important to note that the clearance of desipramine
and desmethyldesipramine from the brain of the juvenile
animals is slower than that of the adult animals. At 27 to
28 h after the last dose, the concentration of desipramine
+ desmethyldesipramine in the juvenile brains is 3.5 times
that of the adult rats, even though the juvenile animals
received a lower dose of desipramine. Over 99% of the
drug is eliminated from the adult brain in 52 h, whereas it
takes over 100 h to eliminate 99% of desipramine from
the juvenile brains. This slow clearance of desipramine in
the juvenile brain is most likely due to a lower activity of
the desipramine metabolizing enzyme(s). This is further
confirmed by the fact that the ratio of desmethyld-
esipramine/desipramine was lower in the juvenile rats
compared to the adult rats suggesting that the rate limiting
step is the conversion of desipramine to desmethyld-
esipramine and not the elimination of desmethyld-
esipramine.
An unexpected finding in these studies was the enhanced
hypothermic effect in adult rats that was obtained 24 h
after the last dose of desipramine. This effect was not seen
14 h after the last dose of desipramine when the
desipramine + desmethyldesipramine brain concentra-
tions were still high or 48 h after the last dose when the
desipramine + desmethyldesipramine levels were negligi-
ble. These results suggest a transient rebound effect either
on the α2-adrenoceptors or on down-stream mechanisms
regulating body temperature. An enhanced hypothermic
effect has been observed when guanfacine is used to
decrease temperature after 21 days of desipramine treat-
ment, but an attenuation of the hypothermic response
when clonidine was used as the agonist [12]. Others have
also reported an attenuation of the clonidine-induced
hypothermic effect 24 h after repeated treatment with
desipramine [12,25], imipramine [19,26] and
amitripyline [27,28]. These results suggest that the effects
of desipramine on drug-induced hypothermic response
may depend on the agonist used, the receptors that are
activated, and/or the extent of receptor activation.
The juvenile animals clearly respond differently to both
the acute effects of desipramine and to the enhancement
of brimonidine-induced hypothermic response after
repeated desipramine treatment. In the adult animals the
repeated effect of desipramine on agonist-induced hypo-
thermic response was transient and occurred when most
of the drug had been eliminated. However, in the juvenile
rats, the brimonidine-induced hypothermic effect was the
same in desipramine and saline-treated animals at all
times studied including at 63 h when most of the drug had
been eliminated.
Conclusion
These results indicate a distinct difference in the ability of
rats pretreated with desipramine to regulate the agonist
induced-hypothermic response of α2-adrenoceptors in
post-natal day 13 rats following acute and repeated
desipramine treatment compared to adult rats. Potential
explanations for the lack of an effect of repeated-
desipramine injections in the juvenile rats are that the
norepinephrine transporters and the mechanisms regulat-
ing the α2-adrenoceptors are not fully developed in this
age group.
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